TEMA ONCOLOGY ETF (CANC:NASDAQ)

$39.8199 0.8939 (2.2964%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 81

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed TEMA ONCOLOGY ETF (CANC:NASDAQ) News Sources

Here's Why Biotech ETFs Are Rallying Hard

09-01-2026

yahoo.com

Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance

02-12-2025

yahoo.com

Be Thankful to These ETFs This Year

26-11-2025

yahoo.com

Inside the Recent Strength in Biotech ETFs

21-11-2025

yahoo.com

CANC stock
CANC stock price
CANC stock price today
CANC stock prediction
CANC earnings date
CANC news
CANC price
CANC share
CANC share price
CANC shares
CANC ceo
CANC premarket
$CANC
CANC ticker
CANC after hours
CANC stock
CANC stock price
CANC stock price today
CANC stock prediction
CANC earnings date
CANC news
CANC price
CANC share
CANC share price
CANC shares
CANC ceo
CANC premarket
$CANC
CANC ticker
CANC after hours

TEMA ONCOLOGY ETF (CANC:NASDAQ) Sentiment Trend

View FAQ

TEMA ONCOLOGY ETF (CANC:NASDAQ) FAQs

toggle

What is the current price of TEMA ONCOLOGY ETF (CANC:NASDAQ)?

The current price of TEMA ONCOLOGY ETF (CANC:NASDAQ) is $39.8199.


toggle

TEMA ONCOLOGY ETF (CANC:NASDAQ) absolute price change since previous trading day?

The absolute price change of TEMA ONCOLOGY ETF (CANC:NASDAQ) since the previous trading day is $0.8939.


toggle

TEMA ONCOLOGY ETF (CANC:NASDAQ) percentage price change since previous trading day?

The percentage price change of TEMA ONCOLOGY ETF (CANC:NASDAQ) since the previous trading day is 2.2964%.


toggle

What is the most recent average sentiment score for TEMA ONCOLOGY ETF (CANC:NASDAQ)?

The most recent average sentiment score for TEMA ONCOLOGY ETF (CANC:NASDAQ) is 81 out of 100.


toggle

What is the most recent average sentiment for TEMA ONCOLOGY ETF (CANC:NASDAQ)?

The most recent sentiment for TEMA ONCOLOGY ETF (CANC:NASDAQ) is .


SEC-8K** Filing Available For TEMA ONCOLOGY ETF (CANC:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.